Remodulin
| Covered Uses: |
All FDA-approved indications not otherwise excluded from Part D. |
| Exclusion Criteria: |
|
| Required Medical Information: |
|
| Age Restrictions: |
|
| Prescriber Restrictions: |
Coverage is provided in situations where it is being prescribed under the care or referral of a cardiologist or pulmonologist. |
| Coverage Duration: |
12 months |
| Other Criteria: |
Coverage is provided for use in combination with two or more PAH therapies when treatment with one PAH agent failed to adequately control the patient’s symptoms. |
Last Modified on 12/19/2012